Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Executive Summary
The Global Transcatheter Tricuspid Valve Intervention (TTVI) market is projected to display noteworthy growth and estimated to reach value of USD 10.17 billion by the year 2030 with Europe region leading the regional market share. Demand for transcatheter valvular therapeutics for tricuspid valve diseases in line with rising aged population globally that are more prone to such diseases is likely to boost the market growth. Moreover, tricuspid valve intervention (repair and replacement) device developments and their upcoming medical approvals across countries is also creating positive outlook for the market growth.
European region is estimated to be the fastest growing regional market for the TTVI in the forecast period of 2021-25, whereas Asia-Pacific will take the lead in the second half from 2026-30. The growth of the European market can be attributed to early approvals of some tricuspid valve repair devices, rising burden of tricuspid valve disorders, ageing population and high per-capita healthcare spending in regional countries. Whereas, APAC region growth will witness lucrative growth owing to factors like huge unmet needs of patients suffering from tricuspid valve disorders, rapidly expanding healthcare infrastructure, surge in medical tourism and rising healthcare spending by both public and private sectors in the regional countries. Meanwhile, North America will hold the second biggest share in TTVI market and will grow at a robust pace as well.
The emergence of COVID-19 has brought the world to a standstill. This health crisis has brought an unprecedented impact on businesses across industries, including the cardiovascular (heart) care and other related industries. The COVID-19 epidemic has disrupted the clinical & confirmatory trials, pipeline milestones, or regulatory clearances and approvals of tricuspid valve repair & replacement devices in different nations because of lockdowns, travel boycotts, and implementation of "stay-at-home" orders. With the suspension or delay of screening, medical association's approvals and clinical trial activities, COVID-19 has fundamentally reshaped clinical & surgical practice at every level.
Rising prevalence of tricuspid valve diseases, increasing preference for transcatheter tricuspid valve intervention devices for treatment, and technological advancements leading to enhanced applications of Transcatheter Tricuspid Valve Intervention. Furthermore, the growing preference for minimally-invasive surgeries over traditional/open heart surgeries will drive the utilization of TTVI procedures, such as valve repair and replacement interventions. These factors, in turn, are projected to fuel the demand for Transcatheter Tricuspid Valve Intervention over the coming years.
Scope of the Report
• The report analyses the Transcatheter Tricuspid Valve Intervention Market by value (USD Millions).
• The report analyses the Transcatheter Tricuspid Valve Intervention Market by Intervention Type (Tricuspid Valve Repair (TVr) and Tricuspid Valve Replacement (TVR)).
• The report analyses the Transcatheter Tricuspid Valve Intervention Market by Disease Type (Tricuspid Regurgitation (TR) and Tricuspid Stenosis (TS))
• The report analyses the Transcatheter Tricuspid Valve Intervention Market by End User (Hospitals, Ambulatory Surgical Centers, Others)
• The Global Transcatheter Tricuspid Valve Intervention Market has been analysed By Region (North America, Europe, Asia Pacific, and LAMEA).
• The Global Transcatheter Tricuspid Valve Intervention Market has been analysed By Country (United States, Canada, Germany, United Kingdom, France, Italy, China, Japan, India, and Australia).
• The key insights of the report have been presented through the frameworks of SWOT Analysis and Product pipeline. Also, the attractiveness of the market has been presented by region, by Intervention Type, by Disease Type and by End User.
• Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product developments. The companies analysed in the report include Edwards Lifesciences, Abbott, Medtronic PLC, LivaNova PLC, CryoLife, Venus MedTech, NaviGate Cardiac Structures, Jenscare Biotech., Huihe Medical, and 4Tech Cardio Ltd.
• The report presents the analysis of Transcatheter Tricuspid Valve Intervention Market for the forecast period of 2021-2030.
Key Target Audience
• Transcatheter Tricuspid Valve Intervention Products Manufacturers
• Pharmaceutical Industry
• Biotechnology Companies
• Government and Research Organisations
• Consulting and Advisory Firms
• Investment Banks and Equity Firms
List of Figures
Figure 1: Global Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 2: Global Expected Number of Transcatheter Tricuspid Valve Intervention (Repair and Replacement) Procedures (In thousands), Year 2020 - 2030E
Figure 3: Global Aged Population (Above 65), 2015-20 (% of total Population)
Figure 4: Global Aged Population (Above 65), By Country, 2020 (% of total Population)
Figure 5: Current Healthcare Expenditure (% Share of GDP), By Selected Country, 2014-2018 (In %)
Figure 6: Global Transcatheter Tricuspid Valve Intervention Market- By Intervention Type Market Share, 2025 & 2030
Figure 7: Global Transcatheter Tricuspid Valve Intervention Market- By Tricuspid Valve Repair, By Value (USD Million), 2021-2030
Figure 8: Global Transcatheter Tricuspid Valve Intervention Market- By Tricuspid Valve Replacement, By Value (USD Million), 2021-2030
Figure 9: Global Transcatheter Tricuspid Valve Intervention Market- By Disease Type Market Share, 2025 & 2030
Figure 10: Global Transcatheter Tricuspid Valve Intervention Market- By Tricuspid Regurgitation, By Value (USD Million), 2021-2030
Figure 11: Global Transcatheter Tricuspid Valve Intervention Market- By Tricuspid Stenosis, By Value (USD Million), 2021-2030
Figure 12: Global Transcatheter Tricuspid Valve Intervention Market- By End User Market Share, 2025 & 2030
Figure 13: Global Transcatheter Tricuspid Valve Intervention Market- By Hospitals, By Value (USD Million), 2021-2030
Figure 14: Global Transcatheter Tricuspid Valve Intervention Market- By Ambulatory Surgery Centers, By Value (USD Million), 2021-2030
Figure 15: Global Transcatheter Tricuspid Valve Intervention Market- By Others, By Value (USD Million), 2021-2030
Figure 16: Global Transcatheter Tricuspid Valve Intervention Market- By Region Market Share, 2025 & 2030
Figure 17: North America Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 18: North America Current health expenditure per capita (current USD), 2014-18
Figure 19: North America Population ages 65 and above (% of total Population), 2016-20
Figure 20: North America Diabetes Prevalence, By Country, 2020 (% of Population Aged 20 to 79)
Figure 21: North America Transcatheter Tricuspid Valve Intervention Market- By Intervention Type, By Value (USD Million), 2021-2030
Figure 22: North America Transcatheter Tricuspid Valve Intervention Market- By Disease Type, By Value (USD Million), 2021-2030
Figure 23: North America Transcatheter Tricuspid Valve Intervention Market- By End User, By Value (USD Million), 2021-2030
Figure 24: Market Opportunity Chart of North America Transcatheter Tricuspid Valve Intervention Market- By Country, By Value (Year-2030)
Figure 25: North America Transcatheter Tricuspid Valve Intervention Market- By Country Market Share, 2025 & 2030
Figure 26: United States Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 27: United States Current health expenditure per capita (current USD), 2014-18
Figure 28: United States Population aged 65 and above (% of total Population), 2016-20
Figure 29: Percent of adults aged 18+ with obesity crude Prevalence in the U.S., 2014-218
Figure 30: United States Transcatheter Tricuspid Valve Intervention Market- By Intervention Type, By Value (USD Million), 2021-2030
Figure 31: United States Transcatheter Tricuspid Valve Intervention Market- By Disease Type, By Value (USD Million), 2021-2030
Figure 32: United States Transcatheter Tricuspid Valve Intervention Market- By End User, By Value (USD Million), 2021-2030
Figure 33: Canada Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 34: Canada Current health expenditure per capita (current USD), 2014-18
Figure 35: Canada Population aged 65 and above (% of total Population), 2016-20
Figure 36: Canada Transcatheter Tricuspid Valve Intervention Market- By Intervention Type, By Value (USD Million), 2021-2030
Figure 37: Canada Transcatheter Tricuspid Valve Intervention Market- By Disease Type, By Value (USD Million), 2021-2030
Figure 38: Canada Transcatheter Tricuspid Valve Intervention Market- By End User, By Value (USD Million), 2021-2030
Figure 39: Europe Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2025-2030 (USD Million)
Figure 40: Europe Population ages 65 and above (% of total Population), 2016-20
Figure 41: European Countries Population ages 65 and above (% of total Population), 2020
Figure 42: Europe Current health expenditure per capita (current USD), 2014-18
Figure 43: Europe Diabetes Prevalence, By Country, 2020 (% of Population Aged 20 to 79)
Figure 44: Europe Transcatheter Tricuspid Valve Intervention Market- By Intervention Type, By Value (USD Million), 2021-2030
Figure 45: Europe Transcatheter Tricuspid Valve Intervention Market- By Disease Type, By Value (USD Million), 2021-2030
Figure 46: Europe Transcatheter Tricuspid Valve Intervention Market- By End User, By Value (USD Million), 2021-2030
Figure 47: Market Opportunity Chart of Europe Transcatheter Tricuspid Valve Intervention Market- By Country, By Value (Year-2030)
Figure 48: Europe Transcatheter Tricuspid Valve Intervention Market- By Country Market Share, 2025 & 2030
Figure 49: Germany Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2025-2030 (USD Million)
Figure 50: Germany Healthcare Industry Scenario (2016-2019)
Figure 51: Germany Population ages 65 and above (% of total Population), 2016-20
Figure 52: Germany Transcatheter Tricuspid Valve Intervention Market- By Intervention Type, By Value (USD Million), 2021-2030
Figure 53: Germany Transcatheter Tricuspid Valve Intervention Market- By Disease Type, By Value (USD Million), 2021-2030
Figure 54: Germany Transcatheter Tricuspid Valve Intervention Market- By End User, By Value (USD Million), 2021-2030
Figure 55: United Kingdom Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 56: United Kingdom Current health expenditure per capita, PPP (current int. USD), 2014-18
Figure 57: United Kingdom Population ages 65 and above (% of total Population), 2016-20
Figure 58: United Kingdom Transcatheter Tricuspid Valve Intervention Market- By Intervention Type, By Value (USD Million), 2021-2030
Figure 59: United Kingdom Transcatheter Tricuspid Valve Intervention Market- By Disease Type, By Value (USD Million), 2021-2030
Figure 60: United Kingdom Transcatheter Tricuspid Valve Intervention Market- By End User, By Value (USD Million), 2021-2030
Figure 61: Italy Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 62: Italy Current health expenditure per capita (current USD), 2014-18
Figure 63: Italy Population ages 65 and above (% of total Population), 2016-20
Figure 64: Italy Transcatheter Tricuspid Valve Intervention Market- By Intervention Type, By Value (USD Million), 2021-2030
Figure 65: Italy Transcatheter Tricuspid Valve Intervention Market- By Disease Type, By Value (USD Million), 2021-2030
Figure 66: Italy Transcatheter Tricuspid Valve Intervention Market- By End User, By Value (USD Million), 2021-2030
Figure 67: France Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 68: France Current health expenditure per capita (current USD ), 2014-18
Figure 69: France Population ages 65 and above (% of total Population), 2016-20
Figure 70: France Transcatheter Tricuspid Valve Intervention Market- By Intervention Type, By Value (USD Million), 2021-2030
Figure 71: France Transcatheter Tricuspid Valve Intervention Market- By Disease Type, By Value (USD Million), 2021-2030
Figure 72: France Transcatheter Tricuspid Valve Intervention Market- By End User, By Value (USD Million), 2021-2030
Figure 73: Asia Pacific Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2025-2030 (USD Million)
Figure 74: Asia Pacific, Current health expenditure per capita (current USD), 2014-18
Figure 75: Asia Pacific, Population ages 65 and above (% of total Population), 2016-20
Figure 76: Asia Pacific, Current health expenditure per capita, by countries (current USD), 2018
Figure 77: Asia Pacific Population ages 65 and above, by Countries (% of total Population), 2020
Figure 78: Asia Pacific Diabetes Prevalence, By Country, 2020 (% of Population Age 20 to 79)
Figure 79: Asia Pacific Transcatheter Tricuspid Valve Intervention Market- By Intervention Type, By Value (USD Million), 2021-2030
Figure 80: Asia Pacific Transcatheter Tricuspid Valve Intervention Market- By Disease Type, By Value (USD Million), 2021-2030
Figure 81: Asia Pacific Transcatheter Tricuspid Valve Intervention Market- By End User, By Value (USD Million), 2021-2030
Figure 82: Market Opportunity Chart of APAC Transcatheter Tricuspid Valve Intervention Market- By Country, By Value (Year-2026)
Figure 83: APAC Transcatheter Tricuspid Valve Intervention Market- By Country Market Share, 2025 & 2030
Figure 84: China Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 85: China Current health expenditure per capita (current USD), 2014-18
Figure 86: China Population ages 65 and above (% of total Population), 2016-20
Figure 87: China Transcatheter Tricuspid Valve Intervention Market- By Intervention Type, By Value (USD Million), 2021-2030
Figure 88: China Transcatheter Tricuspid Valve Intervention Market- By Disease Type, By Value (USD Million), 2021-2030
Figure 89: China Transcatheter Tricuspid Valve Intervention Market- By End User, By Value (USD Million), 2021-2030
Figure 90: Japan Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 91: Japan Healthcare Expenditure Outlook (%)
Figure 92: Japan Population ages 65 and above (% of total Population), 2016-20
Figure 93: Japan Transcatheter Tricuspid Valve Intervention Market- By Intervention Type, By Value (USD Million), 2021-2030
Figure 94: Japan Transcatheter Tricuspid Valve Intervention Market- By Disease Type, By Value (USD Million), 2021-2030
Figure 95: Japan Transcatheter Tricuspid Valve Intervention Market- By End User, By Value (USD Million), 2021-2030
Figure 96: India Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 97: India Current health expenditure per capita (current USD), 2014-18
Figure 98: India Population ages 65 and above (% of total Population), 2016-20
Figure 99: India Transcatheter Tricuspid Valve Intervention Market- By Intervention Type, By Value (USD Million), 2021-2030
Figure 100: India Transcatheter Tricuspid Valve Intervention Market- By Disease Type, By Value (USD Million), 2021-2030
Figure 101: India Transcatheter Tricuspid Valve Intervention Market- By End User, By Value (USD Million), 2021-2030
Figure 102: Australia Transcatheter Tricuspid Valve Intervention Market Size, By Value, 2021-2030 (USD Million)
Figure 103: Australia Current health expenditure per capita (current USD), 2014-18
Figure 104: Australia Population ages 65 and above (% of total Population), 2016-20
Figure 105: Australia Transcatheter Tricuspid Valve Intervention Market- By Intervention Type, By Value (USD Million), 2021-2030
Figure 106: Australia Transcatheter Tricuspid Valve Intervention Market- By Disease Type, By Value (USD Million), 2021-2030
Figure 107: Australia Transcatheter Tricuspid Valve Intervention Market- By End User, By Value (USD Million), 2021-2030
Figure 108: Market Attractiveness Chart of Global Transcatheter Tricuspid Valve Intervention Market- By Intervention Type (Year-2030)
Figure 109: Market Attractiveness Chart of Global Transcatheter Tricuspid Valve Intervention Market- By Intervention Type (Year-2030)
Figure 110: Market Attractiveness Chart of Global Transcatheter Tricuspid Valve Disease Market- By End User (Year-2030)
Figure 111: Market Attractiveness Chart of Global Transcatheter Tricuspid Valve Intervention Market- By Region (Year-2030)
Figure 112: Edwards Lifesciences Annual Sales Revenue, 2021-2025 (USD Million)
Figure 113: Edwards Lifesciences Net Income, 2021-2025 (USD Million)
Figure 114: Edwards Lifesciences Sales Revenue, By Business Segment (%), FY2020
Figure 115: Edwards Lifesciences Sales Revenue, By Geographical Segment (%), FY2020
Figure 116: Abbott Laboratories Sales Revenue, 2021-2025 (USD Million)
Figure 117: Abbott Laboratories Net Income, 2021-2025 (USD Million)
Figure 118: Abbott Laboratories Sales Revenue, By Business Segment (%), FY2020
Figure 119: Abbott Laboratories Sales Revenue, By Geographical Segment (%), FY2020
Figure 120: Medtronic PLC Annual Sales Revenue, 2021-2025 (USD Million)
Figure 121: Medtronic PLC Net Income, 2021-2025 (USD Million)
Figure 122: Medtronic PLC Sales Revenue, By Business Segment (%), FY2020
Figure 123: Medtronic PLC Sales Revenue, By Geographical Segment (%), FY2020
Figure 124: LivaNova PLC Annual Sales Revenue, 2021-2025 (USD Million)
Figure 125: LivaNova PLC Net Income, 2021-2025 (USD Million)
Figure 126: LivaNova PLC Sales Revenue, By Business Segment (%), FY2020
Figure 127: LivaNova PLC Sales Revenue, By Geographical Segment (%), FY2020
Figure 128: CryoLife Annual Sales Revenue, 2021-2025 (USD Million)
Figure 129: CryoLife Net Income, 2021-2025 (USD Million)
Figure 130: CryoLife Sales Revenue, By Business Segment (%), FY2020
Figure 131: CryoLife Sales Revenue, By Geographical Segment (%), FY2020
Figure 132: Venus MedTech Annual Sales Revenue, 2021-2025 (USD Million)
Figure 133: Venus MedTech Net Income, 2021-2025 (USD Million)
Figure 134: Venus MedTech Sales Revenue, By Business Segment (%), FY2020
Figure 135: Venus MedTech Sales Revenue, By Geographical Segment (%), FY2020
| Price : US$ 3,500 |
Date : Dec 2024 |
| Category : Services |
Pages : 167 |
| Price : US$ 3,500 |
Date : Nov 2024 |
| Category : Services |
Pages : 156 |
| Price : US$ 3,500 |
Date : Sep 2024 |
| Category : Services |
Pages : 174 |
| Price : US$ 3,160 |
Date : Jul 2024 |
| Category : Services |
Pages : 185 |
Request Sample 
Request Discount 
Inquire Before Buy
